Shelley Allen,Steven W. Andrews,Kevin Ronald Condroski,Julia Haas,Lily Huang,Yutong Jiang,Timothy Kercher,Jeongbeob Seo
申请号：
US15401913
公开号：
US20170119770A1
申请日:
2017.01.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Compounds of Formula I:and salts thereof in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.
